Charles Schwab’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.78M | Buy |
|
|||||
|
2025
Q2 | $3.18M | Buy |
|
|||||
|
2025
Q1 | $2.62M | Buy |
|
|||||
|
2024
Q4 | $2.7M | Sell |
|
|||||
|
2024
Q3 | $4.38M | Buy |
|
|||||
|
2024
Q2 | $4.45M | Buy |
|
|||||
|
2024
Q1 | $7.24M | Buy |
|
|||||
|
2023
Q4 | $5.88M | Buy |
|
|||||
|
2023
Q3 | $5.36M | Buy |
|
|||||
|
2023
Q2 | $5.96M | Buy |
|
|||||
|
2023
Q1 | $5.48M | Buy |
|
|||||
|
2022
Q4 | $6.52M | Buy |
|
|||||
|
2022
Q3 | $7.37M | Buy |
|
|||||
|
2022
Q2 | $6.78M | Sell |
|
|||||
|
2022
Q1 | $9.54M | Sell |
|
|||||
|
2021
Q4 | $9.43M | Buy |
|
|||||
|
2021
Q3 | $11.9M | Buy |
|
|||||
|
2021
Q2 | $10.3M | Buy |
|
|||||
|
2021
Q1 | $8.38M | Buy |
|
|||||
|
2020
Q4 | $9.37M | Buy |
|
|||||
|
2020
Q3 | $5.61M | Sell |
|
|||||
|
2020
Q2 | $7.95M | Buy |
|
|||||
|
2020
Q1 | $6.57M | Buy |
|
|||||
|
2019
Q4 | $8.08M | Buy |
|
|||||
|
2019
Q3 | $6.86M | Buy |
|
|||||
|
2019
Q2 | $9.55M | Sell |
|
|||||
|
2019
Q1 | $12M | Buy |
|
|||||
|
2018
Q4 | $8.1M | Buy |
|
|||||
|
2018
Q3 | $14.1M | Buy |
|
|||||
|
2018
Q2 | $10.3M | Buy |
|
|||||
|
2018
Q1 | $4.03M | Buy |
|
|||||
|
2017
Q4 | $4.26M | Buy |
|
|||||
|
2017
Q3 | $4.04M | Buy |
|
|||||
|
2017
Q2 | $1.93M | Buy |
|
|||||
|
2017
Q1 | $1.42M | Buy |
|
|||||
|
2016
Q4 | $1.29M | Buy |
|
|||||
|
2016
Q3 | $920K | Buy |
|
|||||
|
2016
Q2 | $327K | Buy |
|
|||||
|
2016
Q1 | $249K | Buy |
|
|||||
|
2015
Q4 | $376K | Buy |
|